Regulatory
How to Work with FDA on Voluntary Recalls
By Mary Borneman, Sr. Director, Communications & Public Affairs, Standard Homeopathic Company/Hyland’s, Inc. In April 2019, U.S. Food & Drug Administration (FDA) published a draft guidance* Initiation of Voluntary…
Read MoreInitiation of Voluntary Recalls: Draft Guidance for Industry and FDA Staff
By Mark Land, AAHP President Product recalls are an important tool that manufacturers and the U.S. Food and Drug Administration (FDA) use to minimize exposure to potentially harmful or…
Read MoreOverview: Membership Meeting 2019
The membership of AAHP came together on March 8 for the association’s semiannual Membership Meeting. Taking place during Natural Products Expo West in Anaheim, Calif., AAHP members convened to hear…
Read MoreReduce Risk with Product Substantiation
Susan J. Hewling When bringing products to market, it is essential to build a platform that allows all information generated to be available for future use,” advised Susan J.…
Read MoreNew Congress, New Landscape: What it Means for the Homeopathic Industry
By Pete Evich, AAHP Government Relations Shutdown Impacts FDA The 116th Congress commenced on Jan. 3 amidst a turbulent backdrop of a partial federal government shutdown. On Jan. 25, after…
Read MoreOutlook 2019: A Letter from the Board
By AAHP Board of Directors 2019 presents a unique crossroad to the homeopathic industry. As consumer demand for our products rises across North America, so does industry growth—and it is…
Read MoreAccelerating into the New Year
By Mark Land, AAHP President As the homeopathic industry continues to grow, AAHP recognizes the need for constant improvement. This year, building on the momentum we gained in 2018,…
Read MoreMid-Term Election Results: What the Homeopathic Industry Needs to Know
By Pete Evich, AAHP Government Relations The outcome of the November elections will translate into some significant changes on Capitol Hill over the next two years. In contests for the…
Read More2018: A Fast-Paced Year of Advocacy and Education
By AAHP Board of Directors It’s been nearly a year since the U.S. Food and Drug Administration (FDA) published a draft guidance document that would revoke clearly detailed parameters for…
Read MoreA Brief Regulatory History of Process Validation
By Mark Land, AAHP President Finished product testing is probabilistic and not dispositive of process control; that is why we need process validation. While preparing this article I came…
Read More